Han lämnar Neurovive

Bolagets vd Mikael Brönnegård lämnar sin tjänst.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Han föreslås bli Diamyds nya styrelseordförande

Efter att ett ägarkonsortium krävt att styrelsen i forskningsbolaget Diamyd byts ut läggs ett förslag på efterträdare nu fram.

45 miljoner till biologiska läkemedel

Genom ett nytt forskningsprogram vill Vinnova och Vetenskapsrådet främja svensk utveckling och tillverkning av biologiska läkemedel.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

Changing e-solutions for clinical trials

Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...

Mingling types - who to aim for and who to avoid:

Read about different mingling types - who are you?

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Han tar plats i den virtuella ledningsgruppen

Advokaten Stefan Wendén tar plats i forskningsparken Medeons första virtuella ledningsgrupp.

Recipharm launches into biologics manufacturing

Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Framåt för Sobi

Efter gårdagens kvartalsrapport som slog förväntningarna får bolagets läkemedel Alprolix godkänt i Schweiz.

Oasmia får FDA-ok för djurläkemedel

Godkännandet ger bolaget ekonomisk stabilitet, menar vd.

Han ska ta in kapital åt tillväxtbolagen

För att öka tillgången på externt kapital för tillväxtbolagen i Sahlgrenska Science Park inrättas en ny tjänst.

BMAs: Run your own business

After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...

Per Hammargren, Sales Director, ICU Scandinavia AB

Why are you going to Scanlab and Biotech Forum?

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

How to get the most out of the fair

Rapid system for surface hygiene monitoring

The Clean-Trace Surface Testing Instruments are a rapid solution to monitor biological contamination on surfaces in real time to help customers manage their cle...

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Lägger ner arbetet med hjärtinfarkt

Efter negativa resultat från fas III-studien Circus avslutar Neurovive sin utveckling mot akut hjärtinfarkt.

Happy exhibitors!

There were fewer vistors this year but most exhibitors are content.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.